The New York Entrepreneur

Prescription-drug middlemen face mounting bipartisan criticism on Capitol Hill 

Read Time:12 Second

Top executives at the largest U.S. pharmacy-benefit managers sought to defend their business practices on Capitol Hill on Tuesday, as lawmakers on both sides of the aisle excoriated the industry’s impact on the cost and accessibility of prescription drugs.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post UnitedHealth is tapping the bond market as it moves to get ahead of election-related volatility
Next post Bank of America clients bailed out of stocks last week at the fastest pace in years